These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 38088220)
1. Loss of nephric augmenter of liver regeneration facilitates acute kidney injury via ACSL4-mediated ferroptosis. Huang L; Zhang L; Zhang Z; Tan F; Ma Y; Zeng X; Cao D; Deng L; Liu Q; Sun H; Shen B; Liao X J Cell Mol Med; 2024 Feb; 28(3):e18076. PubMed ID: 38088220 [TBL] [Abstract][Full Text] [Related]
2. Augmenter of liver regeneration protects the kidney from ischaemia-reperfusion injury in ferroptosis. Huang LL; Liao XH; Sun H; Jiang X; Liu Q; Zhang L J Cell Mol Med; 2019 Jun; 23(6):4153-4164. PubMed ID: 30993878 [TBL] [Abstract][Full Text] [Related]
3. Augmenter of liver regeneration knockout aggravates tubular ferroptosis and macrophage activation by regulating carnitine palmitoyltransferase-1A-induced lipid metabolism in diabetic nephropathy. Zhang Y; Zhang Z; Huang L; Wang C; Yang P; Zhang L; Liao X Acta Physiol (Oxf); 2024 Jul; 240(7):e14159. PubMed ID: 38767438 [TBL] [Abstract][Full Text] [Related]
4. Augmenter of liver regeneration protects the kidney against ischemia-reperfusion injury by inhibiting necroptosis. Liao YJ; Ma YX; Huang LL; Zhang Z; Tan FY; Deng LL; Cao D; Zeng XJ; Yu GQ; Liao XH Bioengineered; 2022 Mar; 13(3):5152-5167. PubMed ID: 35164651 [TBL] [Abstract][Full Text] [Related]
5. ACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury. Wang Y; Zhang M; Bi R; Su Y; Quan F; Lin Y; Yue C; Cui X; Zhao Q; Liu S; Yang Y; Zhang D; Cao Q; Gao X Redox Biol; 2022 May; 51():102262. PubMed ID: 35180475 [TBL] [Abstract][Full Text] [Related]
6. Augmenter of liver regeneration reduces mitochondria-derived ROS and NLRP3 inflammasome activation through PINK1/Parkin-mediated mitophagy in ischemia-reperfusion-induced renal tubular injury. Zhu D; Zhong J; Gong X; Wu X Apoptosis; 2023 Apr; 28(3-4):335-347. PubMed ID: 36370259 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of augmenter of liver regeneration (ALR) mitigates the effect of H Jiang X; Liao XH; Huang LL; Sun H; Liu Q; Zhang L Apoptosis; 2019 Apr; 24(3-4):278-289. PubMed ID: 30680481 [TBL] [Abstract][Full Text] [Related]
8. Novel insights into the protective effects of leonurine against acute kidney injury: Inhibition of ER stress-associated ferroptosis via regulating ATF4/CHOP/ACSL4 pathway. Cheng R; Wang X; Huang L; Lu Z; Wu A; Guo S; Li C; Mao W; Xie Y; Xu P; Tian R Chem Biol Interact; 2024 May; 395():111016. PubMed ID: 38670420 [TBL] [Abstract][Full Text] [Related]
9. Augmenter of liver regeneration plays a protective role against hydrogen peroxide-induced oxidative stress in renal proximal tubule cells. Xia N; Yan RY; Liu Q; Liao XH; Sun H; Guo H; Zhang L Apoptosis; 2015 Apr; 20(4):423-32. PubMed ID: 25633409 [TBL] [Abstract][Full Text] [Related]
10. Exosomal lncRNA TUG1 derived from human urine-derived stem cells attenuates renal ischemia/reperfusion injury by interacting with SRSF1 to regulate ASCL4-mediated ferroptosis. Sun Z; Wu J; Bi Q; Wang W Stem Cell Res Ther; 2022 Jul; 13(1):297. PubMed ID: 35841017 [TBL] [Abstract][Full Text] [Related]
11. Augmenter of Liver Regeneration Protects Renal Tubular Epithelial Cells From Ischemia-Reperfusion Injury by Promoting PINK1/Parkin-Mediated Mitophagy. Zhu DJ; Liao XH; Huang WQ; Sun H; Zhang L; Liu Q Front Physiol; 2020; 11():178. PubMed ID: 32231587 [TBL] [Abstract][Full Text] [Related]
12. [Effect and mechanism of Jiedu Huoxue Decoction in regulating YAP/ACSL4 pathway to inhibit ferroptosis in treatment of acute kidney injury]. Cheng R; Tian RM; Huang LH; Wang XW; Guo S; Wu AJ; Li C; Chen J; Li SJ; Chen M; Mao W; Xu P Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(1):151-161. PubMed ID: 38403348 [TBL] [Abstract][Full Text] [Related]
13. Augmenter of liver regeneration promotes mitochondrial biogenesis in renal ischemia-reperfusion injury. Huang LL; Long RT; Jiang GP; Jiang X; Sun H; Guo H; Liao XH Apoptosis; 2018 Dec; 23(11-12):695-706. PubMed ID: 30259216 [TBL] [Abstract][Full Text] [Related]
14. miR-208a-3p regulated by circUQCRC2 suppresses ischemia/reperfusion-induced acute kidney injury by inhibiting CELF2-mediated tubular epithelial cell apoptosis, inflammation and ferroptosis. Huang P; Meng L; Pang J; Huang H; Ma J; He L; Lin X Shock; 2024 Jun; 61(6):942-950. PubMed ID: 38664873 [TBL] [Abstract][Full Text] [Related]
15. Augmenter of Liver Regeneration Alleviates Renal Hypoxia-Reoxygenation Injury by Regulating Mitochondrial Dynamics in Renal Tubular Epithelial Cells. Long RT; Peng JB; Huang LL; Jiang GP; Liao YJ; Sun H; Hu YD; Liao XH Mol Cells; 2019 Dec; 42(12):893-905. PubMed ID: 31822044 [TBL] [Abstract][Full Text] [Related]
16. Shenshuaifu Granule Attenuates Acute Kidney Injury by Inhibiting Ferroptosis Mediated by p53/SLC7A11/GPX4 Pathway. Jin X; He R; Lin Y; Liu J; Wang Y; Li Z; Liao Y; Yang S Drug Des Devel Ther; 2023; 17():3363-3383. PubMed ID: 38024532 [TBL] [Abstract][Full Text] [Related]
17. Cyanidin-3-glucoside inhibits ferroptosis in renal tubular cells after ischemia/reperfusion injury via the AMPK pathway. Du YW; Li XK; Wang TT; Zhou L; Li HR; Feng L; Ma H; Liu HB Mol Med; 2023 Apr; 29(1):42. PubMed ID: 37013504 [TBL] [Abstract][Full Text] [Related]
18. MitoQ protects against carbon tetrachloride-induced hepatocyte ferroptosis and acute liver injury by suppressing mtROS-mediated ACSL4 upregulation. Tao L; Xue YF; Sun FF; He X; Wang HQ; Tong CC; Zhang C; Xu DX; Chen X Toxicol Appl Pharmacol; 2024 May; 486():116914. PubMed ID: 38522585 [TBL] [Abstract][Full Text] [Related]
19. Targeted inhibition of CX3CL1 limits podocytes ferroptosis to ameliorate cisplatin-induced acute kidney injury. Gong Q; Lai T; Liang L; Jiang Y; Liu F Mol Med; 2023 Oct; 29(1):140. PubMed ID: 37875838 [TBL] [Abstract][Full Text] [Related]
20. Dexmedetomidine Attenuates Ferroptosis-Mediated Renal Ischemia/Reperfusion Injury and Inflammation by Inhibiting ACSL4 Tao WH; Shan XS; Zhang JX; Liu HY; Wang BY; Wei X; Zhang M; Peng K; Ding J; Xu SX; Li LG; Hu JK; Meng XW; Ji FH Front Pharmacol; 2022; 13():782466. PubMed ID: 35873574 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]